Jane Street’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
74,741
-12,801
| -15% | -$184K | ﹤0.01% | 2780 |
|
|
2025
Q1 | $604K | Buy |
87,542
+64,351
| +277% | +$444K | ﹤0.01% | 3691 |
|
|
2024
Q4 | $123K | Sell |
23,191
-22,521
| -49% | -$119K | ﹤0.01% | 5271 |
|
|
2024
Q3 | $167K | Buy |
45,712
+22,889
| +100% | +$83.5K | ﹤0.01% | 5316 |
|
|
2024
Q2 | $62.3K | Sell |
22,823
-205,412
| -90% | -$561K | ﹤0.01% | 5718 |
|
|
2024
Q1 | $794K | Buy |
228,235
+184,484
| +422% | +$642K | ﹤0.01% | 3481 |
|
|
2023
Q4 | $62.6K | Buy |
+43,751
| New | +$62.6K | ﹤0.01% | 5363 |
|
|
2023
Q2 | – | Sell |
-19,144
| Closed | -$29.3K | – | 6104 |
|
|
2023
Q1 | $29.3K | Buy |
19,144
+6,546
| +52% | +$10K | ﹤0.01% | 5212 |
|
|
2022
Q4 | $21.2K | Buy |
+12,598
| New | +$21.2K | ﹤0.01% | 5057 |
|
|
2022
Q3 | – | Sell |
-10,848
| Closed | -$18K | – | 6479 |
|
|
2022
Q2 | $18K | Buy |
+10,848
| New | +$18K | ﹤0.01% | 5136 |
|
|
2021
Q4 | – | Sell |
-32,264
| Closed | -$203K | – | 6018 |
|
|
2021
Q3 | $203K | Buy |
+32,264
| New | +$203K | ﹤0.01% | 4380 |
|
|
2021
Q2 | – | Sell |
-76,651
| Closed | -$716K | – | 5875 |
|
|
2021
Q1 | $716K | Buy |
+76,651
| New | +$716K | ﹤0.01% | 2925 |
|
|
2018
Q4 | – | Sell |
-21,058
| Closed | -$90K | – | 3973 |
|
|
2018
Q3 | $90K | Buy |
+21,058
| New | +$90K | ﹤0.01% | 3282 |
|